207 results
Page 2 of 11
8-K
EX-99.1
ccg07myas3dz no
10 Nov 22
Biolase Delivers 26% Revenue Growth Year Over Year In Third Quarter and Raises 2022 Full Year Revenue Guidance
4:09pm
8-K
EX-99.1
eeapu8c7
11 Aug 22
Biolase Delivers 34% Revenue Growth Year Over Year In Second Quarter
4:07pm
8-K
EX-99.2
ff6dmtlp4h9agsao4yfo
7 Jul 22
Biolase Enters into Favorable Credit Agreement Amendment
9:35am
424B5
527u48hb7malk s5
29 Jun 22
Prospectus supplement for primary offering
5:25pm
8-K
EX-99.1
joybwm6vlcmhycs
8 Jun 22
Material Modifications to Rights of Security Holders
6:06am
8-K
EX-99.1
p3xxaahslwcst6cs5i
10 Jan 22
Biolase Announces Postive Preliminary Revenue Results for 2021 Fourth Quarter; Enters 2022 with Significant Momentum
6:52am
8-K
EX-99.1
chujl 863byw7
23 Nov 21
Nasdaq Grants Biolase 180-DAY Extension to Meet Minimum Bid Price Requirement and Enters into Favorable Credit Agreement Amendment
5:21pm
DEFA14A
3uwjp7tc79 o87p
25 Oct 21
Additional proxy soliciting materials
5:30pm